ClinicalTrials.gov
public full text
Public Domain
CART-PSMA Cells for Advanced Prostate Cancer
This is a single center, open-label phase 1 study to assess the safety and feasibility of PSMA-specific CAR modified autologous T cells (CART-PSMA cells) in patients with advanced prostate cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- PSMA-specific CAR-T Cell Therapy#873141
- GD2/PSMA Bi-specific CAR-T Cell Therapy#829232
- Stem Cells for Erectile Dysfunction Post RALP#1112756
- PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer#1074551
- CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas#859959
Record · ID 1057474
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive